Keywords: CLH, cutaneous lymphoid hyperplasia; COVID-19; PLEVA, pityriasis lichenoides et varioliformis acuta; cutaneous lymphoid hyperplasia; lymphomatoid papulosis; pityriasis lichenoides et varioliformis acuta; vaccination.